HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yangzhi Cao Selected Research

LSZ102

1/2022Discovery of Thieno[2,3-e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yangzhi Cao Research Topics

Disease

1Hypersensitivity (Allergy)
04/2024
1Breast Neoplasms (Breast Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

1Ammonium CompoundsIBA
04/2024
1catechol (pyrocatechol)IBA
04/2024
1CefiderocolIBA
04/2024
1Cephalosporins (Cephalosporin Antibiotics)IBA
04/2024
1SaltsIBA
04/2024
1Estrogen ReceptorsIBA
01/2022
1LSZ102IBA
01/2022
1TamoxifenFDA LinkGeneric
01/2022

Therapy/Procedure

1Therapeutics
01/2022